Volume | 56,993 |
|
|||||
News | - | ||||||
Day High | 0.645 | Low High |
|||||
Day Low | 0.589849 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
BioNexus Gene Lab Corporation | BGLC | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.645 | 0.589849 | 0.645 | 0.595 | 0.582 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
214 | 56,993 | $ 0.6032087 | $ 34,379 | - | 0.31 - 9.49 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:43:01 | formt | 1,400 | $ 0.5985 | USD |
BioNexus Gene Lab Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
10.42M | 17.67M | - | 11.11M | -356k | -0.02 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
BioNexus Gene Lab News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BGLC Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.62 | 1.00 | 0.58 | 0.7807461 | 885,817 | -0.0215 | -3.47% |
1 Month | 0.686 | 1.00 | 0.58 | 0.7464833 | 300,438 | -0.0875 | -12.76% |
3 Months | 0.47 | 3.39 | 0.4004 | 1.42 | 1,658,762 | 0.1285 | 27.34% |
6 Months | 0.438 | 3.39 | 0.31 | 1.12 | 1,802,900 | 0.1605 | 36.64% |
1 Year | 3.50 | 9.49 | 0.31 | 1.50 | 2,095,118 | -2.90 | -82.90% |
3 Years | 3.50 | 9.49 | 0.31 | 1.50 | 2,095,118 | -2.90 | -82.90% |
5 Years | 3.50 | 9.49 | 0.31 | 1.50 | 2,095,118 | -2.90 | -82.90% |
BioNexus Gene Lab Description
BioNexus Gene Lab Corp is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. It focuses on developing and marketing safe, effective, and non-invasive blood tests for the early detection of diseases. The company's non-invasive blood tests analyze changes in ribonucleic acid (or RNA) to detect the potentiality of 11 different diseases. These diseases include eight cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate, and colon), two bowel diseases (colitis and Crohn), and osteoarthritis. |